Showing results (421-430 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|September 11, 2024
Successful treatment of trichilemmal carcinoma with distant metastasis using pembrolizumab: a case report and reviewLei Liu, Tengfei Long, Nannan Wei, et al.Immunotherapy|September 4, 2024
Successful replacement for recurrent nasopharyngeal carcinoma with cholecystitis induced by PD-1 antibody: a case reportZheqing Liu, Xiaojing Du, Meiling Deng, et al.Immunotherapy|September 13, 2024
Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatmentSofia Tzoumpa, Béatrice Villette, Florence Granel-Brocard, et al.Immunotherapy|September 11, 2024
Good response to cadonilimab as first-line treatment in superaged patient with advanced gastric cancer: a case reportJia Lun, Guikai Ma, Xuan Wang, et al.Immunotherapy|October 7, 2024
A lesson from fatal invasive fungal infections after CAR-T cell therapy: a case report and literature reviewZhengfeng Hou, Danchen Meng, Min Ruan, et al.Immunotherapy|August 19, 2024
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumabAlessandra Damassi, Malvina Cremante, Alessio Signori, et al.Immunotherapy|September 19, 2024
Bimekizumab for the treatment of hidradenitis suppurativaRayad B Shams, Christopher J SayedImmunotherapy|September 17, 2024
Effects of benralizumab in patients with severe eosinophilic asthma (SEA): A plain language summary of the ANANKE studyG W Canonica, L Consani, L Malerba, et al.Immunotherapy|May 11, 2025
A case report of mesalazine alleviating diarrhea in a patient with nasopharyngeal cancer after tislelizumab treatmentXiaomei Zhou, Yu Shu, Xi Chen, et al.Immunotherapy|May 17, 2025
New onset of hypertension associated with immune checkpoint inhibitor therapy in cancer patientsHangYu Watson, Nolan Holley, Tabot Ntoung Nkongho, et al.Pageof 188